Italy
· Delayed Price · Currency is EUR Arterra Bioscience Statistics
Total Valuation
Arterra Bioscience has a market cap or net worth of EUR 13.72 million. The enterprise value is 10.42 million.
| Market Cap | 13.72M |
| Enterprise Value | 10.42M |
Important Dates
The next estimated earnings date is Friday, September 27, 2024.
| Earnings Date | Sep 27, 2024 |
| Ex-Dividend Date | May 6, 2024 |
Share Statistics
Arterra Bioscience has 6.66 million shares outstanding.
| Shares Outstanding | 6.66M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 41.07% |
| Owned by Institutions (%) | 5.05% |
| Float | 3.35M |
Valuation Ratios
The trailing PE ratio is 12.75.
| PE Ratio | 12.75 |
| Forward PE | n/a |
| PS Ratio | 4.11 |
| PB Ratio | 1.28 |
| P/FCF Ratio | 14.29 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.55, with an EV/FCF ratio of 10.85.
| EV / Earnings | 9.68 |
| EV / Sales | 3.12 |
| EV / EBITDA | 6.55 |
| EV / EBIT | 9.83 |
| EV / FCF | 10.85 |
Financial Position
The company has a current ratio of 9.35, with a Debt / Equity ratio of 3.59.
| Current Ratio | 9.35 |
| Quick Ratio | 7.74 |
| Debt / Equity | 3.59 |
| Debt / EBITDA | 0.24 |
| Debt / FCF | 0.40 |
| Interest Coverage | 404.88 |
Financial Efficiency
Return on equity (ROE) is 10.14% and return on invested capital (ROIC) is 5.99%.
| Return on Equity (ROE) | 10.14% |
| Return on Assets (ROA) | 5.27% |
| Return on Capital (ROIC) | 5.99% |
| Revenue Per Employee | 98,126 |
| Profits Per Employee | 31,652 |
| Employee Count | 34 |
| Asset Turnover | 0.27 |
| Inventory Turnover | 1.18 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -1.90% in the last 52 weeks. The beta is 1.08, so Arterra Bioscience's price volatility has been similar to the market average.
| Beta (5Y) | 1.08 |
| 52-Week Price Change | -1.90% |
| 50-Day Moving Average | 2.08 |
| 200-Day Moving Average | 1.90 |
| Relative Strength Index (RSI) | 50.73 |
| Average Volume (20 Days) | 4,238 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Arterra Bioscience had revenue of EUR 3.34 million and earned 1.08 million in profits. Earnings per share was 0.16.
| Revenue | 3.34M |
| Gross Profit | 1.85M |
| Operating Income | 1.06M |
| Pretax Income | 1.30M |
| Net Income | 1.08M |
| EBITDA | 1.59M |
| EBIT | 1.06M |
| Earnings Per Share (EPS) | 0.16 |
Balance Sheet
The company has 3.69 million in cash and 386,084 in debt, giving a net cash position of 3.30 million or 0.50 per share.
| Cash & Cash Equivalents | 3.69M |
| Total Debt | 386,084 |
| Net Cash | 3.30M |
| Net Cash Per Share | 0.50 |
| Equity (Book Value) | 10.75M |
| Book Value Per Share | 1.61 |
| Working Capital | 7.04M |
Cash Flow
In the last 12 months, operating cash flow was 1.03 million and capital expenditures -65,965, giving a free cash flow of 959,911.
| Operating Cash Flow | 1.03M |
| Capital Expenditures | -65,965 |
| Free Cash Flow | 959,911 |
| FCF Per Share | 0.14 |
Margins
Gross margin is 55.46%, with operating and profit margins of 31.75% and 32.26%.
| Gross Margin | 55.46% |
| Operating Margin | 31.75% |
| Pretax Margin | 39.03% |
| Profit Margin | 32.26% |
| EBITDA Margin | 47.70% |
| EBIT Margin | 31.75% |
| FCF Margin | 28.77% |
Dividends & Yields
This stock pays an annual dividend of 0.10, which amounts to a dividend yield of 4.81%.
| Dividend Per Share | 0.10 |
| Dividend Yield | 4.81% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 61.87% |
| Buyback Yield | n/a |
| Shareholder Yield | 4.81% |
| Earnings Yield | 7.85% |
| FCF Yield | 7.00% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |